HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.
HC Wainwright & Co. Reiterates Buy on Pulmatrix, Maintains $10 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Pulmatrix (NASDAQ:PULM) with a Buy and maintains $10 price target.
Related Posts
UBS CEO Reportedly Sees Credit Suisse Takeover As Growth Opportunity: ‘Did Not Buy…Only To Close It’
UBS Group AG (NYSE:UBS) CEO Ralph Hamers reportedly said on Monday the Swiss lender views its government-orchestrated takeover…
Citigroup Maintains Buy Rating for BeiGene: Here’s What You Need To Know
Citigroup has decided to maintain its Buy rating of BeiGene (NASDAQ:BGNE) and raise its price target from $285.00…
$1M Bet On U.S. Bancorp? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed slightly lower on Monday, there were a few notable insider trades.